INTERNATIONAL PATENT: PASITHEA THERAPEUTICS CORP. FILES APPLICATION FOR "SOLID FORMS COMPRISING (5R,6S)-10,11-DIFLUORO-12-((2-FLUORO-4-IODOPHENYL)AMINO)-5,6-DIHYDROXY-4,5,6,7-TETRAHYDRO-1H-SPIRO[BENZO[B][1,5,4]OXATHIAZECINE-3,1'-CYCLOPROPANE] 2,2-DIOXIDE AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME"

GENEVA, July 14 -- PASITHEA THERAPEUTICS CORP. (1111 Lincoln Road, Suite 500Miami, FL 33139) filed a patent application (PCT/US2025/010064) for "SOLID FORMS COMPRISING (5R,6S)-10,11-DIFLUORO-12-((2-FLUORO-4-IODOPHENYL)AMINO)-5,6-DIHYDROXY-4,5,6,7-TETRAHYDRO-1H-SPIRO[BENZO[B][1,5,4]OXATHIAZECINE-3,1'-CYCLOPROPANE] 2,2-DIOXIDE, AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME" on Jan 02, 2025. With publication no. WO/2025/147497, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAZARUS, Mathew (1111 Lincoln Road, Su...